- Type I and II DM:
- Usual total daily insulin requirement 0.5-1 units/kg/day
- Give <15min before or <20min after meals
Pre-filled syringe: 100 IU/ml
- Administered by SC injection in the abdominal wall, thigh or upper arm
- Rotate injection sites within the same region from 1 injection to the next to reduce the risk of lipodystrophy
Rapid-acting insulin
It stimulates peripheral glucose uptake, inhibits hepatic glucose production, inhibits lipolysis and proteolysis regulating glucose metabolism
- Hypoglycemia
- Injection site reaction
- Injection site lipodystrophy
- Myalgia
- Pruritus
- Rash
- URI
- Weight gain
- Headache
- Peripheral edema
- Hypersensitivity reaction
- Influenza
- Hypersensitivity to components
- IM use
- Hypoglycemia
- Pramlintide
Drug Status
| Availability | Prescription only |
| Pregnancy | Category B; Can be used |
| Breastfeeding | Can be used |
| Schedule | Not controlled |
| BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
|---|---|---|---|---|---|
| Apidra Solostar | 100 IU/mL | Pre-Filled Syringe | 5*3mL | Sanofi-Aventis | Ressourcethica Kenya |